tiprankstipranks
Axsome Therapeutics Inc. (AXSM)
NASDAQ:AXSM
US Market
AXSM
Axsome Therapeutics
RESEARCH TOOLSreports
Want to see AXSM full AI Analyst Report?

Axsome Therapeutics (AXSM) Stock News & Sentiment

2,370 Followers
Truist’s Suvannavejh Lifts Auvelity Outlook and Sets $310 Price Target on Axsome Therapeutics Buy Rating
Premium
Ratings
Truist’s Suvannavejh Lifts Auvelity Outlook and Sets $310 Price Target on Axsome Therapeutics Buy Rating
15d ago
AXSM
Buy Rating Reiterated as Auvelity’s Expanded Alzheimer’s Opportunity Drives Upgraded $276 Price Target
Premium
Ratings
Buy Rating Reiterated as Auvelity’s Expanded Alzheimer’s Opportunity Drives Upgraded $276 Price Target
19d ago
AXSM
Axsome Therapeutics Earnings Call Signals Aggressive Growth
Premium
Company Announcements
Axsome Therapeutics Earnings Call Signals Aggressive Growth
19d ago
AXSM
Axsome Highlights Strong Q1 Growth and AUVELITY Expansion
Premium
Company Announcements
Axsome Highlights Strong Q1 Growth and AUVELITY Expansion
19d ago
8K
AXSM
AXSM Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
AXSM Upcoming Earnings Report: What to Expect?
22d ago
AXSM
Axsome Wins FDA Nod for Alzheimer’s Agitation Drug
Premium
Company Announcements
Axsome Wins FDA Nod for Alzheimer’s Agitation Drug
23d ago
8K
AXSM
Axsome Therapeutics: Auvelity’s Best‑in‑Class Potential in Alzheimer’s Agitation Supports Buy Rating
Premium
Ratings
Axsome Therapeutics: Auvelity’s Best‑in‑Class Potential in Alzheimer’s Agitation Supports Buy Rating
1M ago
AXSM
More AXSM News >

AXSM News on the Web

Axsome Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript
GuruFocus News
Neutral
Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer’s Agitation Launch
MarketBeat
Bullish
Analysts Are Bullish on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX), Axsome Therapeutics (AXSM)
TipRanks News
Bullish
Truist’s Suvannavejh Lifts Auvelity Outlook and Sets $310 Price Target on Axsome Therapeutics Buy Rating
TipRanks News
Bullish
Axsome Therapeutics price target lowered to $280 from $281 at Deutsche Bank
TipRanks News
Bullish
Axsome Therapeutics price target raised to $267 from $255 at Needham
TipRanks News
Bullish
Axsome Therapeutics price target raised to $242 from $217 at Morgan Stanley
TipRanks News
Neutral
Axsome Therapeutics price target raised to $302 from $242 at RBC Capital
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
AXSM
Sector Average
Media Buzz
This Week1 articles
Weekly Average14.5 articles
News Sentiment
This Week59%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AXSM’s Media Buzz Sentiment?
1 articles about AXSM were published this week. In an average week, 14.5 articles are published.
    What is AXSM’s weekly average amount of articles?
    In an average week, 14.5 articles about AXSM are published.
      What is AXSM’s News Sentiment?
      59% of articles about AXSM were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week